Trudy Lieberman

Conservative notions about the "undeserving poor" have returned with a vengeance in the debate over Medicaid, writes contributor Trudy Lieberman.

The Affordable Care Act has done far less to control health care costs than many media accounts would lead you to believe. Columnist Trudy Lieberman shows how reporters can cut through the spin.

"We are now in another war of words over health care," writes Trudy Lieberman, "and the first casualty, as in any war, is always truth." For examples, look no further than the recent dialogue on Medicare.

The failures of the national conversation during the run-up to Obamacare's passage are now hastening its demise, with too few Americans seeing firsthand benefits.

Trump's election victory has spurred new fears of changes to Medicare. But the move to privatize Medicare has been underway for decades, with Medicare Advantage representing the movement's most recent guise.

Republicans, with their relentless insistence on repealing and replacing the ACA, have reframed the discussion of what’s politically possible to achieve in America at the moment.

Donald Trump and Hillary Clinton are merely the latest in a long line of American politicians who have cast aspersions on the Canadian health care system. Here's what they don't get.

What's known as the "public option" has been given a fresh push by Clinton's campaign and the Democratic Party this year. But while the Obamacare problems it seeks to address are real, it's an unlikely solution.

Here we check in with prominent health journalists and experts to see what sites, newsletters and social media feeds they turn to first every morning. This week, we caught up with Trudy Lieberman, contributing editor to the Center for Health Journalism and Columbia Journalism Review.

At its core, l’affaire EpiPen is not about a single drug maker making sky’s-the-limit profits. It’s about how we pay for pharmaceuticals, how we contain price increases, and ultimately, who gets to use the drugs.